These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 2281806
1. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H. Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806 [Abstract] [Full Text] [Related]
2. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Nov; 241(1):22-30. PubMed ID: 1832302 [Abstract] [Full Text] [Related]
3. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study. Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S. Acta Psychiatr Scand Suppl; 1991 Nov; 365():18-27. PubMed ID: 1862730 [Abstract] [Full Text] [Related]
5. A trend analysis of changes during treatment of panic disorder with alprazolam and imipramine. Mellergård M, Lorentzen K, Bech P, Ottosson JO, Rosenberg R. Acta Psychiatr Scand Suppl; 1991 Nov; 365():28-32. PubMed ID: 1862731 [Abstract] [Full Text] [Related]
6. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR. J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889 [Abstract] [Full Text] [Related]
7. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS. J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912 [Abstract] [Full Text] [Related]
8. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder? Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Apr; 241(3):151-8. PubMed ID: 1790160 [Abstract] [Full Text] [Related]
10. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia. Klerman GL. J Psychiatr Res; 1990 Apr; 24 Suppl 2():27-41. PubMed ID: 1980697 [Abstract] [Full Text] [Related]
11. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Swinson RP, Pecknold JC, Kuch K. Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr; 11(2-3):105-13. PubMed ID: 3628823 [Abstract] [Full Text] [Related]
12. Efficacy of benzodiazepines in panic disorder and agoraphobia. Ballenger JC. J Psychiatr Res; 1990 Apr; 24 Suppl 2():15-25. PubMed ID: 1980694 [Abstract] [Full Text] [Related]
13. Is buspirone effective for panic disorder? Sheehan DV, Raj AB, Sheehan KH, Soto S. J Clin Psychopharmacol; 1990 Feb; 10(1):3-11. PubMed ID: 2407755 [Abstract] [Full Text] [Related]
14. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G. Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715 [Abstract] [Full Text] [Related]
15. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL. Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480 [Abstract] [Full Text] [Related]
16. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia]. León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A. Acta Psiquiatr Psicol Am Lat; 1990 May; 36(1-2):59-72. PubMed ID: 2073024 [Abstract] [Full Text] [Related]
17. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Schweizer E, Rickels K, Weiss S, Zavodnick S. Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222 [Abstract] [Full Text] [Related]
18. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Rosenberg R, Bech P, Mellergård M, Ottosson JO. Acta Psychiatr Scand Suppl; 1991 Jan; 365():39-45. PubMed ID: 1862733 [Abstract] [Full Text] [Related]
19. Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study. Buller R, Maier W, Goldenberg IM, Lavori PW, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Jan; 240(3):163-8. PubMed ID: 1827602 [Abstract] [Full Text] [Related]
20. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. Charney DS, Woods SW. J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]